Skip to content

Issues & Campaigns
Resources
News Center
Who We Are
Contact

Issues & Campaigns
Resources
News Center
Who We Are
Contact

Factsheets & Memos

HEALS' Lender Safe Harbor Provision

08/01/2020

Loading...

Taking too long?

Reload document

|

Open in new tab

RELATED RESOURCES

Letters to Policymakers

TI BD and TI US Letter Urging a Swift Investigation Into Misappropriated Assets by Former Bangladeshi Officials TI BD and TI US Letter Urging a Swift Investigation Into Misappropriated Assets by Former Bangladeshi Officials

Letters to Policymakers

TI US Comment on Strengthening and Modernizing Financial Institutions’ AML and CFT Programs TI US Comment on Strengthening and Modernizing Financial Institutions’ AML and CFT Programs

Letters to Policymakers

TI US Comment on Second Draft Anti-Money Laundering Rule for Investment Advisers TI US Comment on Second Draft Anti-Money Laundering Rule for Investment Advisers

Factsheets & Memos

ENABLERS Act: Stop the Enablers of Fentanyl and Other Drug Trafficking ENABLERS Act: Stop the Enablers of Fentanyl and Other Drug Trafficking

Factsheets & Memos

ENABLERS Act: Disrupt the Financing of U.S. and Global Security Threats ENABLERS Act: Disrupt the Financing of U.S. and Global Security Threats

Presentations & Testimonies

TI US Executive Director Gary Kalman’s Congressional Testimony on the Corporate Transparency Act’s Implementation TI US Executive Director Gary Kalman’s Congressional Testimony on the Corporate Transparency Act’s Implementation

Stay in the know

Sign up for anticorruption updates, news from our office and upcoming events

email *

Email

Visit TI’s Global Homepage at Transparency.org

Issues & Campaigns
Resources
News Center
- Who We Are

Contact Us

General Inquiries

Address
c/o Open Gov Hub
1100 13th St NW,
Suite 800
Washington, DC 20005

Terms Of Use
Privacy

© 2024 Transparency International